Abstract:Purpose: Overexpression of extracellular matrix metalloproteinase inducer (EMMPRIN), a member of the immunoglobulin family and a glycoprotein enriched on the surface of many types of tumor cells, has been reported to be linked to invasion, metastasis, growth, and survival of malignant cells. Cervical cancer, the second most prevalent cancer in women worldwide and the fifth leading cause of cancer deaths, responds to radiotherapy variably, with 30% of cases recurring after therapy. The purpose of this study was to determine whether expression of EMMPRIN affects the response of cervical cancer to radiation therapy, and whether this membrane protein can be used as a prognostic marker for cervical cancer.Experimental Design: The retrospective cohort study included 82 patients with invasive cervical cancer referred to the Department of Gynecologic Oncology at The Cancer Hospital of Fudan University (Shanghai) between 1991 and 2000. These patients were treated with brachytherapy at a dose of 15 Gy at point A before radical hysterectomy. Expression of EMMPRIN in cervical tumor specimens was examined by immunohistochemistry staining before and after brachytherapy and scored for both staining intensity and percentage of tumor cells stained. EMMPRIN immunoreactivity and clinicopathologic data were analyzed with respect to survival end points using univariate and multivariate approaches.Results: The frequency of EMMPRIN overexpression was 52.4% in primary cervical cancer. After brachytherapy, EMMPRIN overexpression was significantly reduced (13.4%) compared with corresponding tumor before brachytherapy (P = 0.032). EMMPRIN expression was associated with pelvic lymph node metastasis (P = 0.026) and reduction in primary tumor volume following brachytherapy (P = 0.008). Although EMMPRIN expression before or after brachytherapy did not correlate with tumor-specific survival, but increased expression of EMMPRIN following brachytherapy tended to predict poor outcomes by univariate survival analysis (P = 0.0008). In addition, lymph vascular space invasion, deep stromal invasion, and lymph node metastasis were significantly associated with poor prognosis. In multivariate analysis, the independent prognostic factors for tumor-specific survival included the decreased expression of EMMPRIN after brachytherapy (P = 0.002; hazard ratio, 0.339; 95% confidence interval, 0.172-0.672) as well as lymph node metastasis (P = 0.044; hazard ratio, 2.053; 95% confidence interval, 1.020-4.133).Conclusion: Expression of EMMPRIN was associated with a decrease in the reduction of cervical tumor following brachytherapy, and increased EMMPRIN expression after brachytherapy seemed to be an important predictor of poor survival in this patient cohort. Our study suggests that expression of EMMPRIN confers resistance to radiotherapy. Therefore, EMMPRIN expression in cervical cancer may be regarded both as a prognostic factor and a therapeutic target.

Evaluation of EMMPRIN (CD147) Expression in Cervical Cancer: a Critical Role in Development and Progression

[Increased Expression of Extracellular Matrix Metalloproteinase Inducer Through Interaction Between Fibroblasts and Colonic Cancer Cells].

Effects of Fibroblasts-Colorectal Cancer Cells Interaction on EMMPRIN Expression in Colorectal Cancer Cells

EMMPRIN Expression As a Prognostic Factor in Radiotherapy of Cervical Cancer

Long Non Coding RNA, C8orf49, a Novel Diagnostic and Prognostic Biomarker, Enhances PTEN/FZD4-mediated Cell Growth and Metastasis by Sponging Mir-1323 in Endometriosis.

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

High incidence of EMMPRIN expression in human tumors

Expression and CD147,MMP-9 and P-Erk in Invasive Ductal Carcinoma of Breast and Its Significance

Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma

Up-regulated EMMPRIN/CD147 Protein Expression Might Play a Role in Colorectal Carcinogenesis and Its Subsequent Progression Without an Alteration of Its Glycosylation and Mrna Level

Expression of Interleukin - 10,E26 Transformation Factor - 1 and Tumor - Associated Macrophages in Cervical Cancer

The Expression of Matrirx Metalloproteinase and Tissue Inhibitor of Metallo-proteinase in Endometrial Child Care

Relationship Between Expression of MMP-9 and TIMP-1 and Cancer Cell Proliferation,Invasion and Metastasis in Invasive Carcinoma of Cervix

EMMPRIN regulates tumor growth and metastasis by recruiting bone marrow-derived cells through paracrine signaling of SDF-1 and VEGF

Soluble extracellular matrix metalloproteinase inducer (EMMPRIN, EMN) regulates cancer-related cellular functions by homotypic interactions with surface CD147

Study of molecular markers in patients with endometrial carcinoma and its prognosis on the effectiveness

EMMPRIN promotes spheroid organization and metastatic formation: comparison between monolayers and spheroids of CT26 colon carcinoma cells

STUDY ON EXPRESSION AND SIGNIFICANCE OF MMP-9 AND PCNA IN CERVICAL CARCINOMA BY TISSUE MICROARRAY

TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma

The Overexpression Membrane Type 1 Matrix Metalloproteinase Is Associated With The Progression And Prognosis In Breast Cancer

EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer